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Abstract The expression patterns of the class I homeogenes 
HOXB and HOXC clusters in the presence of retinoic acid (RA) 
were studied in two human small-cell lung cancer (SCLC) cell 
lines and compared to that of NT2/D1 embryonal carcinoma 
cells. Contrasting with the sequential 3'-5' induction of the HOX 
genes observed after RA treatment of embryonic NT2/D1 cells, 
in the SCLC cells the responding genes (induced or down-
regulated) were interspersed with insensitive genes (expressed or 
unexpressed), while no genomic alteration affected the corre-
sponding clusters. These findings imply that HOX gene 
regulatory mechanisms are altered in non-embryonic SCLC 
cells, perhaps reflecting their ability to respond to more 
diversified stimuli, in relation with their origin from adult tissues. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Homeobox containing genes are a family of evolutionarily 
highly conserved transcription factors (reviewed in [1,2]). The 
class I homeogenes encode proteins containing a homeodo-
main closely related to that of the archetypal Drosophila an-
tennapedia domain. In human, the 39 members of the HOX 
family are tandemly arranged in four clusters of 90-120 kilo-
bases borne by chromosomes 7 (HOXA), 17 {HOXB), 12 
(HOXC) and 2 (HOXD) [3]. Within the clusters, each gene 
can be assigned to one of 13 paralogous groups, with succes-
sively higher numbered paralogous groups being located more 
5' within each cluster. The expression of class I homeogenes is 
strictly regulated temporally and spatially during embryonic 
development [4]. The genes are expressed in overlapping do-
mains, displaying unique anterior boundaries of expression 
for each gene, colinear with their order within the cluster. 
All-trans retinoic acid (RA) is both an important signaling 
molecule in embryonic development and cell differentiation 
[5,6] and a useful drug for the treatment of several types of 
cancer [7]. In embryonal carcinoma (EC) cells, the expression 
of class I homeogenes can be modulated by RA [6,8-10]. 
HOX genes are activated by RA in a sequential order, co-
linear with their 3'-5' localization in the cluster: genes in 3' 
respond early to treatment, whereas upstream genes respond 
progressively later, a situation corresponding to the anterior 
to posterior pattern of expression in the embryo (temporal 
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colinearity). Similar sequential responses were obtained after 
inhibition of HOX gene expression by antisense oligodeoxy-
nucleotides [11]. These data suggest a cascade mechanism in 
the regulation of HOX gene expression, operating on extended 
regions, with 3'-5' polarity [8]. 
Two types of RA binding proteins mediate RA effects : the 
cellular RA binding proteins, CRABP1 and 2, and the RA 
receptors, RARoc, ß and y. The roles of CRABP1 and 
CRABP2 are only partially understood. It has been proposed 
that CRABP1 sequesters RA in the cytoplasm and prevents 
its nuclear uptake [12]. RARs are ligand dependent inducible 
transcription factors (reviewed in [13]). The RARs can acti-
vate gene expression directly through RA responsive elements 
(RAREs) localized in their target genes. Functional RAREs 
are currently known for only a few HOX genes [8]. 
After embryogenesis, HOX genes continue to be transcribed 
according to a tissue specific pattern of expression. In cancer 
cells, alterations of this pattern, as compared to the corre-
sponding normal mature tissues, have been described (re-
viewed in [2,14]). However, few data are available on HOX 
gene regulation in adult tissues. 
Using two small-cell lung cancer (SCLC) cell lines, we re-
port here that, in these mature tissue derived cells, the sequen-
tial 3'-5' induction of the HOX genes by RA is not observed. 
In contrast, the responding genes (induced or down-regulated) 
are interspersed with insensitive genes (expressed or unex-
pressed). 
2. Materials and methods 
2.1. Cell culture and treatments 
The human EC cell line NT2/D1 was obtained from the American 
Type Culture Collection (Rockville, MD, USA) and grown in DMEM 
medium supplemented with 10% fetal calf serum. SCLC cell lines were 
obtained from human xenografted SCLC previously characterized 
[15,16]. The SCLC cells were grown in RPMI medium supplemented 
with 10% fetal calf serum. A stock solution (10 mM) of RA was 
prepared in ethanol and appropriately diluted with culture medium 
at optimal concentrations, according to each cell line's responsiveness. 
The culture medium containing RA was changed every 2 days with 
freshly prepared RA containing solution. We checked that the addi-
tion of ethanol alone did not influence the expression of the studied 
genes. RNAs were prepared using a Trizol kit according to the man-
ufacturer's instructions (Life Technologies, Gaithersburg, MD, USA). 
Two successive Trizol extractions were performed. 
2.2. Gene expression analysis 
The primers used for reverse transcription-polymerase chain reac-
tion (RT-PCR) analysis of the HOXB1-9 [16], HOXBB [17], RARa, 
P and y [18] and CRABP2 [19] expression have previously been re-
ported. The oligonucleotides used for RARs did not discriminate be-
tween the various isoforms. The primers synthesized for the present 
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study are listed in Table 1. Human sequences were available only for 
HOXC4, HOXC5 and HOXC6. For the other genes of the HOXC 
locus, mouse sequences were available. For these latter genes, the 
primers selected on the mouse sequence were used with human 
cDNA. The RT-PCR products were cloned and sequenced by the 
dideoxynucleotide method to confirm the specificity of the primers. 
Sequence analyses were performed using the computer facilities of the 
Bisance server [20]. Homologies between human and mouse sequences 
were in the 95-98% range. The nucleotide sequences have been de-
posited with the GenBank/EMBL Data Libraries (accession numbers: 
X99630, X99631, X99679, X99680, X99681, X99682, X99683, 
X99684, X99685). Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) expression was unaffected by RA treatment and served as 
a control of expression using primers purchased from Clontech (Palo 
Alto, CA, USA). When the amplified fragments did not include any 
intron, control experiments were performed in which the reverse tran-
scription step was omitted to ensure the absence of contaminating 
DNA. Reverse transcription was performed using the Life Technolo-
gies kit with 2 ng of total RNA, 200 ng of oligo-d(T) and 0.5 mM of 
each dXTP. One-tenth of the preparation was used for PCR amplifi-
cation. The buffer conditions were those recommended by the Taq-
polymerase supplier (Appligene-Oncor, Illkirch, France). The ampli-
fication procedure involved denaturation at 94°C for 1 min, annealing 
for 1 min at the appropriate temperature and extension at 72°C for 
1 min during 38^M) PCR cycles. Reaction products were analyzed on 
a 2% agarose gel, labelled with 1 ug/ml of ethidium bromide and 
revealed under UV illumination. The images were captured by a 
CCD camera and the intensity of the bands quantified using Image 
software in the range of linearity of the signal. 
In order to obtain comparable levels of detection for the expression 
of the HOX genes, the number of PCR cycles necessary to detect 100 
molecules of target segments was determined for each gene. The 
threshold of detection was defined as the electrophoretic specific 
band having an intensity of five times the background level. The 
target segments were prepared by RT-PCR, purified (Geneclean III, 
BiolOl, Vista, CA, USA) and quantified on gel by comparison with 
commercially available quantified molecular weight markers (Life 
Technologies). Genomic DNA was also used when no intron was 
present in the amplified DNA. Using 38 cycles for B6, B9, 39 cycles 
for Bl, B2, B7 and 40 cycles for the remaining genes, the same thresh-
old of detection could be obtained for each HOX gene in the exper-
imental conditions used. The reproducibility of the band intensities 
varied by a factor of 1-2 taking into account all the experimental 
variations. The RA treatments of the cells were independently re-
peated 5 (SCLC-6), 3 (SCLC-10) and 2 (NT2/D1) times. In each 
case, 2-3 reverse transcriptions followed by at least 2 PCR amplifica-
tions for each point were performed. Similar results were obtained in 
each series of experiments. 
2.3. Flow cytometry 
The percentage of dead cells was determined by measuring the 
decreased ability to stain DNA with propidium iodide [21]. 
3. Results 
RA induction of HOXB and HOXC gene expression in the 
EC cell line NT2/D1 was analyzed by RT-PCR. In the ab-
sence of RA (Fig. 1), only HOXC12 and HOXC 13 were ex-
pressed at a low level. In the continuous presence of 10 (J,M 
RA, a 3'-5' induction of HOX expression was observed. In 
cluster B, HOXB1 and HOXB2 mRNA were detected after 2 h 
of treatment whereas HOXB9 was switched on only after 
more than 150 h. HOXB13 remained silent. In locus C, 3'-
5' induction was observed for HOXC4, HOXC5 and HOXC6. 
The four genes from HOXC8 to HOXC 11 were insensitive to 
RA treatment whereas the expression of HOXC12 and 
HOXC13 did not change. When the RA concentration was 
decreased, the same 3'-5' induction was observed with an 
increase in the response time: after 168 h, the induction was 
detectable up to HOXB8 and HOXB4 in the presence of 1 uM 
and 0.1 uM RA, respectively, whereas the HOXC locus genes 
were not induced (not shown). These patterns of expression 
are in full accordance with those previously obtained using 
Northern blot or RNase protection assay [9,10]. The single 
discrepancy concerns HOXC12 which was found to be con-
stitutively expressed in our study. 
In RA free medium, the cell doubling time was about 40 h 
and 60 h for SCLC-6 and SCLC-10, respectively. The prolif-
eration rate of SCLC-10 cells was unaffected in the presence 
of 1 u,M RA whereas a 20% decrease was observed in SCLC-6 
cells cultivated in 0.1 ¡J.M RA containing medium. Exposure 
to RA did not affect the morphology of SCLC-10 cells, which 
grew as floating aggregates. In contrast, SCLC-6 cells, which 
normally grew as monolayers, detached from the plastic sur-
face after about 7 days in the presence of 0.1 uM RA, 
Table 1 
Gene specific primers used to analyse gene expression by RT-PCR 
Gene Primers8 Species" T (°C)C Sized Intron6 Ref.f 
HOXC4 
HOXC5 
HOXC6 
HOXC8 
HOXC9 
HOXC10 
HOXC 11 
HOXC12 
HOXC13 
CRABP1 
S: 5'-
A: 5'-
S: 5'-
A: 5'-
S: 5'-
A: 5'-
S: 5'-
A: 5'-
S: 5'-
A: 5'-
S: 5'-
A: 5'-
S: 5'-
A: 5'-
S: 5'-
A: 5'-
S: 5'-
A: 5'-
S: 5'-
A: 5'-
CAGTATAGCTGCACCAGTCTCCAGG-3' 
-GATCTGCCTCTCAGAGAGGCACAGC-3 ' 
TGGATGACCAAACTGCACATGAGC-3' 
-CAAGTTGTTGGCGATCTCTATGCG-3' 
CACCTTAGGACATAACACACAGACC-3' 
-CACTTCATCCGGCGGTTCTGGAACC-3' 
CCACGTCCAAGACTTCTTCCACGGC-3 ' 
-CACTTCATCCTTCGATTCTGAAACC-3 ' 
TGGTTTCAGACCCGGAGGATCAAG-3' 
-GGAAGAGAACGCAGTTTCTCTCC-3 ' 
CTACCGCCTGGAACAACCTGTTGG-3 ' 
- ATGGTCTTGCTAATCTCCAGGCG-3 ' 
AGAAGCGCTGCCCTTATTCG-3' 
- AT ACTGC AGCCGGTCTCTGC-3 ' 
AAAGAAGGCGCAAGCCGTATTCGAAG-3' 
- AGACGTTGCTCCCTCAGCAGAAGTC-3 ' 
TGCCCTATACCAAGGTGCAG-3' 
-TAGATTTGCTGACCACCTTT-3 ' 
AAGATGCGCAGCAGCGAGAATTTCG-3' 
-AAGTTCATCGTTGGCCAGCTCACG-3' 
H 
H 
H 
H 
M 
M 
M 
M 
M 
H 
65 
62 
62 
60 
60 
60 
60 
60 
60 
60 
406 
149 
317 
449 
436 
662 
191 
192 
173 
333 
+ 
+ 
+ 
+ 
-
+ 
-
-
-
+ 
[29] 
[30] 
[29] 
[31] 
[32] 
[33] 
[33] 
[33] 
[33] 
[34] 
"Selected sense (S) and antisense (A) oligodeoxynucleotides. bHuman (H) or mouse (M) origin of the known gene sequence. cHybridization 
temperature. dSize in base pairs of the fragment generated by RT-PCR. "Presence (+) or absence (—) of an intron in the corresponding genomic 
DNA. 'References of the sequences used. 
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Fig. 1. RT-PCR analyses of HOXB and HOXC gene expression in the NT2/D1 cell line. Cells were treated with 10 u.M RA for 2-168 h. 
RNAs were extracted from treated and untreated cells. RT-PCR was performed using primers specific for each HOX gene. GAPDH expression 
was used as control. The reaction products were analyzed by agarose gel electrophoresis and stained with ethidium bromide. The images were 
captured by a CCD camera and processed using Image software. 
although they were still dividing. In 1 u,M RA, the transition 
of SCLC-6 cells from attached to unattached was achieved 
after 2 days. RA toxicity differed between the two SCLC 
cell lines. SCLC-6 was highly sensitive: after 10 days in 0.1 
uM RA, the percentage of dead cells was 20% while it was 3% 
in the untreated cell controls. SCLC-10 cells were more resist-
ant to RA with about 10% of dead cells after 10 days in the 
presence of 1 uM RA, compared to 8% in the absence of RA. 
The data presented below were obtained from experiments 
performed at RA concentrations and for treatment periods 
for which more than 80% of the cells were alive. 
Expression of RARa, ß and y and of CRABP1 and 
CRABP2 genes was studied as a function of time and RA 
concentration by RT-PCR (Fig. 2). RARa and y were consti-
tutively expressed and RAR$ unexpressed in both cell lines. In 
the presence of RA, SCLC-6 and SCLC-10 cells produced 
RARfi mRNA, while the levels of expression of RARa and 
RARy remained unchanged. When RA was removed, expres-
sion of RARß returned to its initial level after few days (not 
shown). CRABP2 was expressed in both cell lines, CRABP1 
in SCLC-10 only. Their pattern of expression did not change 
during RA treatment. 
In SCLC-6 cells cultivated in RA free medium, HOXB4 and 
HOXC6 to HOXC9 were strongly expressed whereas 
HOXC 11 mRNA was detectable at a low level (Figs. 3 and 
4). The HOXB locus was completely switched off in SCLC-10 
cells whereas in locus C, five genes (HOXC6 to HOXC9 and 
HOXC12) were expressed, the level of expression of HOXC6 
being low. The pattern of expression was characteristic of 
these two cell lines and remained unchanged as a function 
of the passage numbers in culture. 
In SCLC-6 cells, transcripts from genes HOXB3, HOXB5, 
HOXB8 and HOXB9 appeared after 2 days of culture in 0.1 
uM RA containing medium (Fig. 3), and accumulated pro-
gressively as a function of the time of treatment. HOXB2, 
HOXB6 and HOXB7 gene expression became detectable after 
4 days. Neither HOXB1 nor HOXB13 transcripts were ob-
served even after 10 days. In the presence of 1 uM RA, similar 
but accelerated expression patterns were seen for HOXB3, 
HOXB5, HOXB8 and HOXB9, which were detectable from 
day 1 of treatment, with HOXB2, HOXB6 and HOXB7 being 
detected on day 2. Again, HOXB1 and HOXB13 were not 
detectable, even after 3 days (not shown). In SCLC-6 cells, 
HOXB1 could be slightly switched on after 7 days in the 
presence of 10 uM RA; such a treatment induced a high level 
of cellular death (not shown). The expression level of HOXB4 
was unaffected by RA treatment. 
In SCLC-10 cells cultured in 0.1 uM RA containing me-
dium, no change in HOXB gene expression was observed for 
up to 10 days (not shown). When the RA concentration was 
increased to 1 uM, HOXB3, HOXB5, HOXB6, HOXB8 and 
HOXB9 transcripts were progressively observed after day 7, 
and no transcripts oiHOXBl, HOXB2, HOXB4, HOXB7 and 
HOXB13 were present even after 10 days. 
The expression of several HOXC genes was unaffected by 
RA treatment independently of their constitutively expressed 
or unexpressed status: HOXC4, HOXC5, HOXC8, HOXC9 
and HOXC13 in both cell lines; HOXC6 in SCLC-6 cells; 
HOXC10 and HOXC11 in SCLC-10 cells (Fig. 4). One con-
stitutively unexpressed gene was weakly induced (HOXC10 in 
SCLC-6), while two initially weakly expressed genes (HOXC6 
in SCLC-10 and HOXC11 in SCLC-6) were slightly induced. 
HOXC 12 was very sensitive to RA: in SCLC-6, the constitu-
tively unexpressed gene was induced, whereas in SCLC-10, the 
constitutively expressed gene was down-regulated. In both cell 
lines, when RA containing medium was removed and replaced 
Fig. 2. RT-PCR analyses of RAR and CRABP expression. Response 
to RA treatments of SCLC-6 and SCLC-10 cell lines. Cells were 
treated with RA for 2, 4 and 7 days at 0.1 uM for SCLC-6 and 
1 uM for SCLC-10. RNAs were extracted from treated and un-
treated cells. RT-PCR was performed using primers specific for the 
three forms of RAR and the two forms of CRABP. GAPDH expres-
sion was used as control. The reaction products were analyzed as 
described in the legend to Fig. 1. 
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by RA free medium, the induced expressions of all the HOX 
genes were retained for 3 days and then returned to their 
initial status by 10 days (not shown). 
Fluorescent in situ hybridization of chromosome specific 
librairies and Southern blot analysis of HOX specific probes 
has shown that the genomic organization of the four HOX 
clusters was not altered in the SCLC cell lines ([16,22] and not 
shown). 
4. Discussion 
In embryonic cells, HOX gene expression is colinear with 
the organization of the genes: the genes at the 3' end of the 
locus are induced rapidly, whereas the time and concentration 
of RA required for induction of gene expression increase with 
increasing distance from the 3' end. This has been previously 
shown by Northern blot and RNase protection assay [9,10]. 
The same behavior can be evidenced by RT-PCR in rigor-
ously controlled conditions as demonstrated here (Fig. 1). 
Several models have been proposed to explain this behavior 
[8,23]. A single RARE localized at the 3' end of the locus 
could sequentially activate the entire HOX cluster. Alterna-
tively, multiple functionally distinct RAREs could coordinate 
HOX gene activity from 3' to 5' in the cluster. The HOX gene 
could also regulate their expression : the product of the gene 
at the 3' end could activate the neighboring gene in the 5' 
direction and so on through the cluster. The RAREs present 
in particular around HOXA1 and HOXB1 allow a complex 
regulation of the expression of these genes [24,25] and data 
have shown the regulation of the HOX gene expression by 
HOX proteins (reviewed in [1,6]). However, the exact mecha-
nisms of RA activation are not yet understood, even if it is 
known that the maintenance of proper timing and polarity is 
assessed by the synthesis of short half-life proteins [10]. 
Regulation of HOX gene expression by RA in the two 
SCLC cell lines derived from mature tissues differs from 
that described in EC cells. In particular, the sequential 3'-5' 
Fig. 3. RT-PCR analyses of HOXB gene expression in RA treated 
SCLC-6 and SCLC-10 cell lines. The cells were grown in the pres-
ence of 0.1 |iM RA (SCLC-6) or 1 uM RA (SCLC-10) for 2, 4, 7 
or 10 days. 
Fig. 4. RT-PCR analyses of HOXC gene expression in RA treated 
SCLC-6 and SCLC-10 cell lines. The cells were grown in the pres-
ence of 0.1 (xM RA (SCLC-6) or 1 uM RA (SCLC-10) for 2, 4, 7 
or 10 days. 
activation is not found. Inside a cluster, very different re-
sponses to RA treatments were seen in the expression patterns 
of neighboring genes, each gene seeming to be induced inde-
pendently. This property is well illustrated by cluster B in 
SCLC-6 cells: HOXB1 and HOXB13 localized respectively 
at the 3' and 5' ends of the cluster are not induced whereas 
gene expression along the cluster is induced with various tim-
ing (Fig. 3). This cannot be related to an alteration of the 
genomic organization of the clusters. The models proposed 
to explain the RA induction of the HOX genes in EC cells 
and in particular the master function of the 3'-most gene of 
the cluster cannot be applied to these cells : in SCLC cells, the 
powerful mechanism which switches off HOXB1 does not pre-
vent the activation of the other genes in the cluster. 
These constitutively expressed genes are insensitive to RA 
treatment excepted HOXC12 which appears to be regulated in 
a more complex manner. It can be activated or repressed by 
similar conditions of RA treatments depending on its consti-
tutive expression status : in SCLC-6, the formerly unexpressed 
genes were induced, whereas in SCLC-10 the constitutively 
expressed genes were down-regulated. In the absence of data 
on the regulation region of this gene, it is currently impossible 
to propose a mechanism of regulation. However, it could be 
associated with RA/AP-1 antagonism (reviewed in [26]). 
Another difference between EC and SCLC cells concerns 
the reversibility of the RA effects. In SCLC cells, the main-
tenance of the HOX gene response depended on the continu-
ous presence of RA in the medium, whereas with EC cells the 
induced HOX genes continue to be expressed after removal of 
RA provided they had been exposed to the inducer for a 
sufficient time [10]. The beginning of the differentiation proc-
ess observed in EC cells after RA treatment must induce an 
irreversible reprogramming of the HOX locus regulatory 
mechanisms lacking in the mature tissue derived SCLC cells. 
Lack of 3'-5' sequential activation of the HOX genes has 
also been observed in other SCLC cell lines and in cell lines 
derived from tumors of mature tissues such as breast and 
colon (not shown). 
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The two SCLC cell lines used responded to R A with differ-
ent extent and behavior: SCLC-10 viability was unaffected by 
the highest dose used (1 uM), whereas SCLC-6 cell viability 
was reduced by a relatively low concentration of R A (0.1 
(iM). These differences in sensitivity may be related to 
CRABP1 expression, only found in SCLC-10 cells. It has 
been proposed that CRABP1 acts as a buffer in the cytoplasm 
by limiting the availability of R A to its nuclear receptors [12]. 
It has also been shown that high levels of CRABP1 reduced 
the expression of several but not all of the R A responsive 
genes in F9 teratocarcinoma cells [27]. The C R A B P l - R A 
complexes are substrates for R A metabolizing enzymes [28]. 
Toxicity of R A in SCLC-10 cells might be attenuated by the 
high level of C R A B P 1 . The role of CRABP1 as an autocrine 
inhibitor of R A effects could also explain the poor response of 
these cells to R A in term of HOX pat tern expression as com-
pared to SCLC-6 cells. 
The mechanisms of regulation of the HOX genes, active 
during embryonic development, seem to be no more effective 
in SCLC cells derived from mature tissues, indicating that the 
regulatory mechanisms may have been reprogrammed. In this 
new context, the HOX genes are not regulated colinearly, 
reminiscent of their role during embryonic development, but 
in a more individual manner corresponding to diversified abil-
ities to respond to external stimuli arising from normal or 
pathological situations. 
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